| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243656 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusions: CONCTX was associated with a reduction in local relapse rates, acceptable cosmesis, and toxicities. These data support the use of concurrent RT and CTX in selected patients at high risk for local failure. Future prospective trials should explore the use of concurrent CTX and RT in high-risk patients using currently employed agents.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bruce G. M.D., Janet H. M.D., Qifeng M.D., Ph.D., Susan A. M.D.,